Notice: Constant WP_DEBUG already defined in /home/content/10/14034110/html/wp-config.php on line 94

Notice: Constant WP_DEBUG_DISPLAY already defined in /home/content/10/14034110/html/wp-config.php on line 97
Contrast-Enhanced Ultrasound Evaluation of Renal Blood Perfusion Changes After Percutaneous Transluminal Renal Angioplasty and Stenting for Severe Atherosclerotic Renal Artery Stenosis - International Contrast Ultrasound Society

Contrast-Enhanced Ultrasound Evaluation of Renal Blood Perfusion Changes After Percutaneous Transluminal Renal Angioplasty and Stenting for Severe Atherosclerotic Renal Artery Stenosis

August 1, 2020 — Ultrasound in Medicine & Biology

Abstract

This study used contrast-enhanced ultrasound (CEUS) to evaluate changes in renal cortical blood perfusion after percutaneous transluminal renal angioplasty and stenting (PTRAS) for severe renal artery stenosis (RAS) (≥70%). CEUS was performed in 21 patients with 24 severe RASs that underwent PTRAS. Renal cortical perfusion was quantitatively evaluated by comparing time intensity curve (TIC) parameters for SonoVue (Bracco, Milan, Italy) contrast enhancement, including peak intensity (PI), time to peak (TTP), mean transmit time (MTT), curve ascending slope (S), area under the curve (AUC), AUC-wash-in and AUC-wash-out. The parameters PI, TTP, MTT and S differed significantly between the pre-intervention and post-intervention TIC analysis (p < 0.05). Of the 24 pre-intervention curve appearances, 58.3% (14/24) improved after operation. The PI difference correlated positively with the estimated glomerular filtration rate difference (r = 0.433, p < 0.05). In conclusion, changes in some ultrasound perfusion parameters on CEUS and the shape of the TIC can be used to quantitatively and intuitively evaluate renal cortical blood perfusion change after PTRAS.

Authors: Xu Ran ⁎, Letao Lin †, Min Yang ‡, Guochen Niu †, Luzeng Chen ⁎, Yuhong Shao ⁎, Yinghua Zou ‡, Bin Wang ⁎

⁎Department of Ultrasound Medicine, Peking University First Hospital, Beijing, P.R. China; †Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China; ‡Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, P.R. China

Volume 46, Issue 8, August 2020, Pages 1872-1879

Read full text at: https://doi.org/10.1016/j.ultrasmedbio.2020.04.006